N	Concordance
1	nt  regimen based on a chemosensitivity assay of tumor specimens collected after
2	e whether the use of a chemosensitivity assay to assign treatment improves the 
3	udent's t test for the chemosensitivity assay (XTT cytotoxicity assay). All P 
4	      by the ATP tumor chemosensitivity assay (ATP-TCA) in a prospective open-la
5	       ATP-based tumor chemosensitivity assay (ATP-TCA) was used to determine th
6	 such as the ATP-tumor chemosensitivity assay allied to selected molecular measu